Registry for tracking outcomes of mitral valve repair procedures
Official title: The Society of Thoracic Surgeons/ American College of Cardiology Transcatheter Valve Therapies Registry Mitral Module
Run by American College of Cardiology · NCT02245763 · Data updated 2026-11-12
This study is tracking the results of mitral valve repair procedures to see how well they work and improve care for patients undergoing this treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Year and up |
| Sex | All |
| Enrollment | 4000 (estimated) |
| Sponsor | American College of Cardiology Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | November 2013 |
| Main results expected | December 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT02245763 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry include all patients undergoing transcatheter mitral valve repair procedures.
✕Probably not a fit
Patients who cannot tolerate anticoagulation or have active endocarditis or rheumatic mitral valve disease may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The TVT Registry is a national surveillance system designed to monitor patient safety and real-world outcomes associated with transcatheter mitral valve repair (TMVR) procedures. It collects standardized data from participating hospitals to assess the quality of care for patients undergoing this treatment. The registry aims to provide confidential reports to healthcare providers to improve care quality and support research based on the collected data. Additionally, it serves as a scalable infrastructure for post-market studies of transcatheter valve therapies.
Why it matters
Potential benefit: If successful, this registry could enhance the safety and effectiveness of mitral valve repair procedures, ultimately improving patient outcomes.
How similar studies have gone: Other national registries for transcatheter valve therapies have shown success in improving patient outcomes and safety monitoring.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients Exclusion Criteria: * Patients who cannot tolerate procedural anticoagulation or post procedural anti-platelet regimen * Active endocarditis of the mitral valve * Rheumatic mitral valve disease * Evidence of intracardiac, inferior vena cava (IVC) or femoral venous thrombus
Where it's running
-
American College of Cardiology
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Study coordinator: Joan K Michaels, RN
- Email: jmichael@acc.org
- Phone: 202-375-6309
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How TAVI and M‑TEER affect sleep‑disordered breathing
This will see if adults with aortic stenosis or mitral regurgitation who undergo TAVI or M‑TEER have improvements in sleep‑disordered breathing six months after their procedure.
-
Mitral and Tricuspid Valve-in-Valve/Valve-in-Ring Registry in Asia-Pacific
This registry tracks people in Asia-Pacific who have had or will have valve-in-valve or valve-in-ring procedures for mitral or tricuspid valve disease to learn about outcomes and safety after these transcatheter approaches.
-
Evaluating heart recovery after surgery for aortic regurgitation
This study looks at how heart surgery for aortic regurgitation helps people with heart problems feel better and recover by checking their heart function and quality of life afterward.
-
Evaluation of the AltaValve System for treating mitral regurgitation
This study is testing a new device called the AltaValve System to see if it can help people with mitral regurgitation who can't have surgery feel better and improve their heart function.
-
Registry for MitraClip treatment of severe mitral valve regurgitation
This study is testing how well the MitraClip G4 device works and is safe for people with severe mitral valve leakage who are getting a specific type of heart repair.
-
New treatment for severe mitral valve insufficiency using a transcatheter valve system
This study is testing a new, less invasive heart valve replacement for older adults with severe mitral valve problems who can't have regular surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.